共 216 条
[1]
Candell-Riera J(1996)Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis Arthritis Rheum 39 1138-1145
[2]
Armadans-Gil L(1990)A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma) J Rheumatol 17 656-662
[3]
Simeón CP(1976)Myocardial lesions of progressive systemic sclerosis A cause of cardiac dysfunction. Circulation 53 483-490
[4]
Castell-Conesa J(2010)Pharmacotherapy of systemic sclerosis Expert Opin Pharmacother 11 789-806
[5]
Fonollosa-Pla V(2010)Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database Ann Rheum Dis 69 1809-1815
[6]
García-del-Castillo H(2013)Pulmonary hypertension in scleroderma and its relation to disease activity Egypt Rheumatol Rehabil 40 173-180
[7]
Follansbee WP(2005)Mortality in systemic sclerosis: an international meta-analysis of individual patient data Am J Med 118 2-10
[8]
Miller TR(2009)Recommendations for the evaluation of left ventricular diastolic function by echocardiography J Am Soc Echocardiogr 22 107-133
[9]
Curtiss EI(2011)Left atrial function: physiology, assessment, and clinical implications Eur J Echocardiogr 12 421-430
[10]
Orie JE(2012)Assessment of left atrial phasic functions in heart failure patients with preserved or low ejection fractions Arch Turk Soc Cardiol 40 122-128